Nasdaq - Delayed Quote USD

PGIM Jennison Health Sciences R (PJHRX)

28.10
+0.36
+(1.30%)
At close: 8:01:58 PM EDT

Performance Overview

Morningstar Return Rating --
YTD Return -10.28%
5y Average Return 6.23%
Number of Years Up 9
Number of Years Down 3
Best 1Y Total Return (May 15, 2025) 55.52%
Worst 1Y Total Return (May 15, 2025) --
Best 3Y Total Return 55.52%
Worst 3Y Total Return 1.87%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
PJHRX
Category
YTD
-3.58%
7.95%
1-Month
-0.63%
4.81%
3-Month
-7.81%
7.18%
1-Year
-1.44%
30.16%
3-Year
7.38%
16.10%
5-Year
9.15%
15.71%
10-Year
6.65%
15.27%
Last Bull Market
8.26%
23.06%
Last Bear Market
-9.50%
-13.88%

Annual Total Return (%) History

Year
PJHRX
Category
2025
--
--
2024
8.12%
--
2023
11.97%
--
2022
-10.65%
--
2021
5.66%
--
2020
40.72%
27.63%
2019
17.71%
26.23%
2018
-4.03%
-0.40%

2017
30.73%
24.31%
2016
-14.84%
-10.60%
2015
4.87%
8.05%
2014
35.18%
27.25%
2013
55.52%
48.17%
2012
--
21.55%

Past Quarterly Returns

YearQ1Q2Q3Q4
2025 -2.97% -- -- --
2024 12.97% -1.44% 4.68% -7.24%
2023 -0.38% 7.51% -5.26% 10.35%
2022 -8.15% -9.50% -3.89% 11.84%
2021 -4.12% 14.05% -5.53% 2.27%
2020 -13.61% 29.49% 9.37% 15.01%
2019 13.54% 1.96% -13.78% 17.93%
2018 0.48% 10.31% 9.02% -20.58%
2017 14.42% 6.68% 5.13% 1.87%
2016 -18.93% 1.57% 9.70% -5.73%

2015 13.19% 5.75% -16.61% 5.07%
2014 7.08% 3.97% 4.40% 16.30%
2013 17.89% 6.44% 17.67% 5.33%
2012 5.11% 7.72% -5.19% --

Rank in Category (By Total Return)

YTD 69
1-Month 47
3-Month 61
1-Year 61
3-Year 7
5-Year 3

Load Adjusted Returns

1-Year -1.44%
3-Year 7.38%
5-Year 9.15%
10-Year 6.65%

Performance & Risk

YTD Return -10.28%
5y Average Return 6.23%
Rank in Category (ytd) 69
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.56
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family PGIM Investments
Net Assets 1.46B
YTD Return -3.58%
Yield 0.54%
Morningstar Rating
Inception Date Jun 30, 1999

Fund Summary

The fund seeks investments whose prices will increase over time. It normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector.

Related Tickers